Although adjuvant chemotherapy after complete resection is not currently recommended for pStage IA NSCLC, future improvements in techniques for detecting micro cancer cells, including decreased albumin, might allow the selection of cases that would benefit from adjuvant chemotherapy. The gene discussed is ALB; the disease is non-small cell lung carcinoma.